Blott Peter J 4
4 · VALEANT PHARMACEUTICALS INTERNATIONAL · Filed Feb 13, 2009
Insider Transaction Report
Form 4
Blott Peter J
EVP & CFO
Transactions
- Award
Common Stock
2008-07-28+47,600→ 73,600 total
Footnotes (1)
- [F1]The restricted stock units are subject to specified performance criteria tied to total shareholder return or other performance criteria as measured on certain specified dates.